New York, NY [January 27, 2025]—The Mount Sinai Hospital has performed New York City’s first procedure using the HYDROS™ Robotic System, a cutting-edge technology designed to treat benign prostatic ...

SAN JOSE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (Nasdaq: PRCT) (“PROCEPT”), a surgical robotics company whose mission is to revolutionize BPH treatment globally, ...

PROCEPT BioRobotics PRCT recently announced FDA 510(k) clearance of its next-generation platform, the HYDROS Robotic System. This clearance marks an important achievement for PROCEPT BioRobotics as ...

CUMMING, Ga.--(BUSINESS WIRE)--PROCEPT BioRobotics Thursday (Sept. 5 th) announced that Northside Hospital Forsyth in partnership with Georgia Urology is the first in the world to offer Aquablation® ...

The Mount Sinai Hospital has performed New York City's first procedure using the HYDROS ™ Robotic System, a cutting-edge technology designed to treat benign prostatic hyperplasia (BPH), or an enlarged ...

The FDA's approval of Procept's Hrydos system is a meaningful catalyst to the investment debate. Investors have added ~$5/share in market value since the announcement. PRCT's Q2 '24 numbers were ...

HACKENSACK, N.J., Sept. 17, 2024 /PRNewswire/ -- On the morning of Wednesday, September 4, 2024, Hackensack Meridian Hackensack University Medical Center became the first hospital in the world to ...

THOMASVILLE — Archbold is now offering Aquablation therapy with the new HYDROS™ Robotic System, the next-generation platform to treat men suffering from benign prostatic hyperplasia (BPH). BPH, ...

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q4 2024 Earnings Call Transcript February 26, 2025 Operator: Good afternoon and welcome to PROCEPT BioRobotics Fourth Quarter and Year End 2024 Earnings ...

SAN JOSE, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative ...